Micro-Caps — page 8
ScanSource to Buy MicroAge in $220.5 Million All-Cash Deal
ScanSource said the acquisition would push it deeper into higher-margin cloud, cybersecurity, data center and AI solutions work.
Clean Energy Technologies' Gross Profit Collapses as China Gas Mix Shifts
Gross profit for the six months ended June 30, 2026 was $3,689, versus $635,535 a year earlier, as China natural gas filled the books and clean-energy system sales vanished.
Francisco Partners to Buy Weave Communications in $650 Million Cash Deal
The acquisition aims to accelerate the development of Weave's AI-powered healthcare platform and expand its revenue cycle management capabilities.
WhiteFiber to Buy North Carolina Industrial Properties in $60 Million Cash Deal
The company intends to use a retrofit-first development strategy to convert the industrial sites into AI data center campuses.
HomeTrust Bancshares to Buy Blue Ridge Bankshares in $448.1 Million All-Stock Deal
The acquisition expands HomeTrust's footprint into Virginia markets to create a regional commercial bank with over $7 billion in assets.
Rates Pinch Credit as Backlogs Signal Uneven Demand
Companies across 14 industries flagged rising borrowing costs and mixed demand signals in their latest disclosures.
Flexsteel's Year-Over-Year Sales Growth Slows to 0.7%
Fourth-quarter net sales were $115.4 million, the eleventh straight year-over-year gain, as IEEPA tariff refunds lifted gross margin to 30.0%.
Supply Chain Disruptions Spread Beyond Tariffs Into Labor and Tech
Six U.S. companies across disparate industries report intensifying multi-modal supply chain constraints spanning tariffs, skilled labor shortages, component bottlenecks, and logistics disruptions.
Chemours and Chiron Lead Weekly Insider Buying Clusters
Six distinct insiders at Chemours and a $2.5 million commitment at Chiron Real Estate headline a week of concentrated open-market activity.
Media Earnings: Demand, Outlook Broadly Upbeat as Costs Diverge
Communications and media companies described a strong demand backdrop and confident guidance for the second quarter of 2026, even as cost management and hiring told a more uneven story.
Materials & Chemicals: Demand and Pricing Firm, Costs Squeeze
Materials and chemicals producers reported broad demand and pricing strength this quarter, but rising input costs ate into much of the gain.
Healthcare Earnings: Demand Surges, Costs Bite Back
Healthcare and pharma companies described broad-based patient and prescription demand alongside investment-heavy capex plans, even as input costs emerged as the one category tilting negative.
Financial Services Earnings: Demand Strong, Costs Bite Back
Financial services companies reported broad demand strength and expanding capex plans in 2026Q2, even as rising input costs and a softening insurance pricing cycle complicated the picture.
Energy Earnings: Demand Runs Hot, Capex Stays Disciplined
Across oilfield services, midstream and E&Ps, management teams described strengthening activity and firming prices while working costs down rather than opening the spending taps.
Banks Post Broad Loan Growth as Funding Costs Ease
Lenders described widespread loan and deposit growth alongside falling deposit costs, even as a chunk of the group flagged rising personnel and technology spending.
Sidus Space's Revenue Growth Reversed
Second-quarter revenue fell 54% to $583,000, reversing the growth Sidus Space had reported at the start of the year.
Neumora Pulls NMRA-215 and NMRA-511 Clinical Starts Earlier
Cash and cash equivalents were $116.8 million as of June 30, 2026, a position the company said is expected to fund operations into the third quarter of 2027.
Cue Books CUE-221 Food-Allergy IND After Licensing
The clinical-stage biopharmaceutical company posted a $153.1 million net loss as it absorbed one-time costs of licensing CUE-221 and then raised $50 million after quarter-end.
Canton Strategic Records First Revenue From Network Operations
Canton Strategic reported $1.50 million in quarterly revenue, largely from locking Canton Coin for network participants, while digital-asset losses dominated its results.
Bimergen Drops Redbird and Wildfire From Ready-to-Build List
The developer still lists about 3.6 gigawatts of alternating-current capacity and now names CAISO among the ISO regions serving that pipeline.
Venu Plans Financing Shift to Keep Venue Real Estate
Venu closed $45 million in interim financing after quarter-end while pursuing longer-term funding to complete two amphitheaters.
TSS Systems Integration Growth Slows After First-Quarter Pace
Second-quarter revenue was $35.1 million as systems integration rose 46% to $13.9 million and procurement fell 45%.
Merlin Completes C-130J Design Review and Autonomous Landing
Second-quarter revenue was $2.2 million as the company posted a $58.4 million GAAP net loss.
MeiraGTx Reclaims Eye Therapy Ahead of Regulatory Push
The genetic medicines company completed its $25 million acquisition of bota-vec and secured financing to support development and potential commercialization.
MacroGenics Completes Bora Sale, Cuts Staff to About 140
Pro forma cash of $327 million as of June 30, 2026, including Bora, Sanofi and Gilead proceeds, underpins runway guidance through 2028.
Lifeway Foods’ Margin Gains Reversed
The kefir maker posted just $0.1 million in second-quarter net income as higher input costs eroded profitability.
Chicago Atlantic BDC Funding Collapses After Record Quarter
Second-quarter investment income was $14.0 million, or $0.61 a share, as the cannabis-focused BDC funded just $2.7 million.
KULR Reverses First-Quarter Revenue Gain and Exits Bitcoin Mining
Second-quarter revenue fell 43% to $2,080,177 and gross margin swung to (31)% after a 98% year-over-year first-quarter increase.
Invivyd Completes Upsized DECLARATION Enrollment
PEMGARDA net product revenue was $14.3 million, up 21% from a year earlier, as the company completed enrollment in its upsized pivotal trial and said cash of $160.1 million should last through the VYD2311 readout.
CapsoVision Capsule Sales Rebound After a Flat First Quarter
Second-quarter revenue reached $3.6 million as capsule volume rose 13% and the company launched AI Highlights in Europe.